UFC bantamweight Amanda Lemos could potentially face the consequences of an anti-doping violation due to failing an out-of-competition drug test
The promotion released a statement relating to the incident on Thursday:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Amanda Lemos of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on November 8, 2017.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Lemos. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.”
Lemos lost by way of second-round TKO to Leslie Smith in July in her promotional debut at UFC Fight Night 113.